As part of coordinated law enforcement actions across the nation in connection with COVID-19 related frauds, federal prosecutors expanded their case against Sunnyvale lab company Arrayit and its president, alleging they misrepresented to investors the development of a coronavirus blood test.
The Department of Justice estimates that more than $143 million in false billings were generated in the schemes they are investigating in seven...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In